Carson Wealth (CWM LLC)
DSGN icon

Carson Wealth (CWM LLC)’s Design Therapeutics DSGN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.5K Buy
423
+184
+77% +$1.86K ﹤0.01% 5062
2025
Q4 		$2K Buy
239
+17
+8% +$133 ﹤0.01% 5072
2025
Q3 		$2K Sell
222
-49
-18% -$245 ﹤0.01% 4991
2025
Q2 		$1K Buy
271
+160
+144% +$599 ﹤0.01% 4987
2025
Q1 		$0 Sell
111
-30
-21% -$143 ﹤0.01% 5087
2024
Q4 		$1K Buy
141
+17
+14% +$98 ﹤0.01% 4691
2024
Q3 		$1K Buy
124
+26
+27% +$122 ﹤0.01% 4558
2024
Q2 		$0 Buy
98
+97
+9,700% +$378 ﹤0.01% 4657
2024
Q1 		$0 Buy
+1
New +$3 ﹤0.01% 4403
2023
Q1 		– Sell
-24
Closed – – 4114
2022
Q4 		$0 Buy
+24
New +$325 ﹤0.01% 4027

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Carson Wealth (CWM LLC)'s DSGN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Design Therapeutics (DSGN) stake by 77% in Q1 2026, buying an estimated $1.86K and bringing the position to 423 shares worth $4.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5062.

Carson Wealth (CWM LLC) first reported a position in DSGN in Q4 2022 and has held it in 10 quarters since. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 423 shares of Design Therapeutics worth $4.5K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 184 Design Therapeutics shares in Q1 2026, an estimated $1.86K.
  • Design Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5062 holding.
  • Carson Wealth (CWM LLC) first reported a position in Design Therapeutics in Q4 2022 and has held it in 10 quarters since.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.